Chemoproteomic Cysteine Selectivity of VVD-446 and VVD-860
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
Global assessment of cysteine selectivity for VVD compounds that covalently engage KEAP1 C151
应用场景：
创建时间：
2025-12-10
相关数据集
Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2
Covalently acting inhibitors constitute a large and growing fraction of approved small-molecule therapeutics as well as useful tools for a variety of in vitro and in vivo applications. Here, we aimed
NIAID Data Ecosystem50
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
The active sites of hundreds of human α-ketoglutarate (αKG) and Fe(II)-dependent dioxygenases are exceedingly well preserved, which challenges the design of selective inhibitors. We identified a nonc
Figshare2018-11-15 更新40
Design, Synthesis, and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (Hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant Prostate Cancer
Androgen deprivation in cases of castration-resistant prostate cancer (CRPC) leads to adverse effects, including loss of muscle and bone mass and gain of subcutaneous fat. The tumor-specific suppressi
Figshare20
Regio- and Stereospecific Synthesis of Oridonin D‑Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads
Covalent drug discovery has undergone a resurgence in recent years due to comprehensive optimization of the structure–activity relationship (SAR) and the structure–reactivity relationship (SRR) for co
Figshare2018-03-20 更新50
Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl‑1 BH3 Mimetics
Covalent drugs provide pharmacodynamic and pharmacokinetic advantages over reversible agents. However, covalent strategies have been developed mostly to target cysteine (Cys) residues, which are rarel
Figshare2024-11-12 更新20
